FOLH1 and prostate carcinoma: PSMA-PET uses radiotracers specifically targeting the prostate-specific membrane antigen (PSMA), a surface protein highly overexpressed by most prostate cancer cells, allowing for highly sensitive and specific detection of prostate cancer manifestations.